Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats

Health Physics

Volumn 89, Issue 1, 2005, Pages 81-88

  Fukuda, Satoshi ^a   Iida, Haruzo ^a   Ikeda, Mizuyo ^a   Yan, Xueming ^b   Xie, Yuyuan ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Chelation; Rat; Toxicity, chemical; Uranium, depleted

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CATECHOL 3,6 BIS(METHYLEIMINODIACETIC ACID); CATECHOL DERIVATIVE; CHELATING AGENT; ETHANE 1 HYDROXY 1,1 BISPHOSPHONATE; UNCLASSIFIED DRUG; URANIUM; URANYL NITRATE; CATECHOL 3,6 BIS(METHYLENEIMINODIACETIC ACID); CATECHOL-3,6-BIS(METHYLENEIMINODIACETIC ACID); ETHANE-1-HYDROXY-1,1-BISPHOSPHONATE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE; CONTROLLED STUDY; DEATH; FECES; FEMUR; KIDNEY; KIDNEY DYSFUNCTION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIMULATION; SURVIVAL RATE; URINE; WOUND; ANIMAL; ANTIBODY SPECIFICITY; CHELATION THERAPY; DOSE RESPONSE; DRUG EFFECT; FOREIGN BODY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PENETRATING TRAUMA; RADIATION INJURY; RADIATION PROTECTION; RADIATION RESPONSE; SURVIVAL; TISSUE DISTRIBUTION; TREATMENT OUTCOME; WISTAR RAT;

RATTUS NORVEGICUS;

ANIMALS; CATECHOLS; CHELATING AGENTS; CHELATION THERAPY; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOREIGN BODIES; INJECTIONS, INTRAMUSCULAR; MEN; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RADIATION INJURIES; RADIATION PROTECTION; RATS; RATS, WISTAR; SURVIVAL; TISSUE DISTRIBUTION; TREATMENT OUTCOME; URANIUM; WOUNDS, PENETRATING;

EID: 21544436009     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000156956.42935.28     Document Type: Article

References (28)

1. Archimbaud M, Henge-Napoli MH, Lilienbaum D, Desloges M, Montagne C. Application of calixarenes for the decorporation of uranium: present limitations and further trends. Radiat Protect Dosim 53:327-330; 1994.
2. Arfsten DP, Still KR, Ritchie GD. A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development. Toxicol Industrial Health 17:180-191; 2001.
3. Basinger MA, Jones MM. Tiron (sodium 4,5-dihydroxybenzene-1,3- disulfonate) as an antidote for acute uranium intoxication in mice. Res Commun Chem Pathol Pharmacol 34:351-358; 1981.
4. Dagirmanjian R, Maynard EA, Hodge HC. The effects of calcium disodium ethylenediamine tetraacetate on uranium poisoning in rats. J Pharmacol Exp Ther 117:20-28; 1956.
5. Domingo JL, Oritega A, Llobet JM, Paternain JL, Corbella J. The effects of repeated parenteral administration of chelating agents on the distribution and excretion of uranium. Res Commun Chem Pathol Pharmacol 64:161-164; 1989.
6. Domingo JL, Oritega A, Llobet JM, Corbella J. Effectiveness of chelation therapy with time after acute uranium intoxication. Fund Appl Toxicol 14:88-95; 1990.
7. Draft ES, Abu-Qare AW, Flaherty MM, Garofolo MC, Rincavage HL, Abou-Donia MB. Depleted and natural uranium: chemistry and toxicological effects. J Toxicol Environ Health B 7:297-317; 2004.
8. Durbin PW, Kullgren B, Xu J, Raymond K. New agents for in vivo chelation of uranium(VI): Efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands. Health Phys 72:865-879; 1997.
9. Fukuda S, Iida H, Hseih Y, Chen W. Toxicological study of DTPA as a drug (V) Toxicities of Ca-DTPA, Ca-EDTA and CBMIDA after intravenous injection in beagle dogs. Hoken Butsuri 25:115-119; 1990.
10. Fukuda S, Iida H, Yan X, Xie X. Effects of CBMIDA on removal of uranium in rats. Biomark Environ 4(Suppl.1):35-37; 2001.
11. Gwiazda RH, Squibb K, McDiarmid K, Smith D. Detection of depleted uranium in urine of veterans from the 1991 Gulf War. Health Phys 86:12-18; 2004.
12. Henge-Napoli MH, Archimbaud M, Ansoborlo E, Metivier H, Gourmelon P. Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration. Int J Radiat Biol 68:389-393; 1995.
13. Henge-Napoli MH, Ansoborlo E, Houpert P, Mirto H, Paquest F, Burgada R, Hodgson S, Stradling GN. Progress and trends in in vivo chelation of uranium. Radiat Protect Dosim 79:449-452; 1998.
14. Henge-Napoli MH, Ansoborlo E, Chazei V, Houpert P, Paquest F, Gourmelon P. Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats. Int J Radiat Biol 75:1473-1477; 1999.
15. Hodge HC. A history of uranium poisoning (1824-1942). In: Hodge HC, Stanard JN, Hursh JB, eds. Uranium, plutonium, transplutonic elements. Berlin: Springer-Verlag; 1973: 5-56.
16. Hooper FJ, Squibb KS, Siegel EL, McPhaul K, Keogh JP. Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys 77:512-519; 1999.
17. Houpert P, Chazel V, Paquet F, Bailly T, Burgada R, Henge-Napoli MH. Reduction of uranium transfer by local chelation in simulated wounds in rats. Human Experiment Toxicol 20:237-241; 2001.
18. Hursh JB, Spoor NL. Data on man. In: Hodge HC, Stanard JN, Hursh JB, eds. Uranium, plutonium, transplutonic elements. Berlin: Springer-Verlag; 1973: 197-235.
19. Leggett RW. The behavior and chemical toxicity of U in the kidney: A reassessment. Health Phys 57:365-383; 1989.
20. Martinez AB, Cabrini RL, Ubios AM. Orally administered ethane-1-hydroxy-1,1-bisphosphonate reduces the lethal effects of oral uranium poisoning. Health Phys 78:668-671; 2000.
21. Martinez AB, Mandalunis PM, Bozal CB, Carbrini RL, Ubios AM. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1,1-bisphosphonate (EHBP). Health Phys 85:343-347; 2003.
22. Mould RF. Depleted uranium and radiation-induced lung cancer and leukaemia. BJR 74:677-683; 2001.
23. Stevens W, Bruenger FW, Atherton DR, Smith JM, Taylor GN. The distribution and retention of hexavalent 233U in the beagle. Radiat Res 83:109-126; 1980.
24. Stradling GN, Gray SA, Moody JC, Ellender M. Efficacy of Tiron for enhancing the excretion of uranium from the rat. Human Experimental Toxicol 10:195-198; 1991.
25. Stradling GN, Hodgson A, Moody JC, Fell TP, Rance E. Exposure limits and assessment of intake for inhaled soluble uranium compounds. Chilton: NRPB; NRPB-M801; 1997.
26. Stradling N, Hodgson A, Ansoborlo E, Berard P, Etherington G, Fell T, LeGuen B. Anomalies between radiological and chemical limits for uranium after inhalation by workers and the public. Radiat Protect Dosim 105:175-178; 2003.
27. Ubios AM, Braun EM, Cabrini RL. Lethality due to uranium poisoning is prevented by ethane-1-hydroxy-1,1-bisphosphonate (EHBP). Health Phys 66:540-544; 1994.
28. Yulle CL. Animal experiments. In: Hodge HC, Stanard JN, Hursh JB, eds. Uranium, plutonium, transplutonic elements. Berlin: Springer-Verlag; 1973: 165-194.